Helping MedTech CDMOs growing business
Strategic Positioning, Market Entry, and Commercial Execution for CDMOs expanding in Europe’s MedTech market.
Key Questions When Entering or Scaling in European MedTech:
-
Why does success in the US or Asia does not translate directly to Europe?
The European supplier and CDMO ecosystem operates with different structures. The CDMO market is fragmented. Contract manufacturing is performed by many small and mid-sized companies. CDMOs are starting to play a more pivotal role; outsourcing has not been seen in the past as a strategic add-on. Historically, in Germany for example, very few OEMs have worked with outsourcing partners before. That represents a significant market opportunity.
-
Are ISO13485 and FDA-registered local sites mandatory to win business?
Certification according to ISO 13485 is expected, as in other countries, especially when working on design and critical programs. Competitive positioning is driven by application and OEM understanding, risk awareness, and reliability in execution. A site presence in Europe is not mandatory to start the business.
-
Where do we fit in the value chain?
The European MedTech supplier landscape ranges from component suppliers to full CDMOs.
Clarity on your role defines which customers you can realistically win. Market entry can be performed by directly approaching OEMs or other players in the ecosystem.
-
Who are we really competing against?
Competition is not limited to similar companies from the same vertical. CDMOs compete across technologies, regions, and integration levels, not just within their own niche. An EMS manufacturer, for example, can compete on the same program against a plastics company without even realizing it. In Europe, competitors are often niche players with dedicated capabilities, technically strong but not very well known internationally.
-
Why should we prioritise Europe?
Germany, Switzerland, Ireland, the Nordics, and Northern Italy represent key anchor regions where many OEM decisions and headquarters are located (similar to Minnesota, California, or New England in the US).
At the same time, manufacturing (mostly cost-driven production) is located in Eastern Europe and other low-cost geographies due to proximity and efficiency. Many of these companies operate globally, meaning that entering Europe quickly becomes both a local and a global discussion, often expanding beyond the initial regional scope.
20+ years in MedTech
Having global experience on both the OEM and CDMO side, I understand the requirements of MedTech OEMs, CDMOs operating in regulated environments,
and speak their language - from components to clinical applications.
-
CDMO Knowledge (components, design & manufacturing projects)
-
Medical OEM experience, Clinical EMS Background
-
Strong track record in business development, and product strategy
-
Regulatory understanding (ISO 13485, MDR, FDA, ISO 14971)
-
Global network & international project execution
The European market is shaped by a mix of EMS providers, plastics specialists, and niche manufactrers. All competing across different parts of the value chain.
This creates blurred boundaries between:
• component suppliers
• contract manufacturers
• and strategic CDMOs
As a result, many companies misjudge where they actually compete.
Where would you place your company on this map?
Source: Alira Health analysis, Global MedTech Contract Manufacturing Report (2024/2025)
Collaboration
European MedTech Entry
Clarification whether a move into European MedTech, and Life Science ecosystem is strategically viable and how to approach it.
Professional Assessment
Analysing your current status: product portfolio, target customers, commercial & sales readiness, regulatory base, technical differentiators, and internal alignment.
Enablement
Support through the implementation phase from assessment and strategic targeting to concrete market actions.
Let´s map where you stand
Hamburg, Germany
The execution can be managed either on-site or remotely within the EU
Don't hesitate to call me
Only the information you send us to contact you in connection with your inquiry will be used, if you request me to do so. For further information, please refer to the privacy policy.